I don't know why the company hasn't mentioned it, but the PXS orbital inhaler (a one-and-done disposable inhaler that delivers a high payload of inhaled antibiotics) is to be trialed for tuberculosis in partnership with the Woolcock Institute (they have previously mentioned this partnership with Woolcock but only in relation to CF).
Tuburculosis effects 14 million people each year and there are 1.4 million deaths. This could be something to watch and yet another high value discovery asset in the PXS pipeline.
Pretty high quality presentation about it on YouTube (date 10 June 2014):
- Forums
- ASX - By Stock
- SNT
- PXS orbital inhaler trial for tuberculosis
PXS orbital inhaler trial for tuberculosis
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
-0.001(2.94%) |
Mkt cap ! $42.58M |
Open | High | Low | Value | Volume |
3.3¢ | 3.3¢ | 3.3¢ | $6.417K | 194.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 106747 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 228097 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 106747 | 0.032 |
2 | 179811 | 0.031 |
9 | 1434343 | 0.030 |
5 | 877931 | 0.029 |
3 | 1780000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 228097 | 1 |
0.034 | 661268 | 3 |
0.035 | 316000 | 2 |
0.036 | 371477 | 3 |
0.039 | 400000 | 1 |
Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |